Cyclo Therapeutics Inc CYTH:NASDAQ

RT Quote | USD
Last | 05/15/24 EDT
1.43quote price arrow up+0.02 (+1.42%)
Volume
11,829
52 week range
0.89 - 2.57
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.41
  • 52 Week High2.57
  • 52 Week High Date06/13/23
  • 52 Week Low0.89
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap41.064M
  • Shares Out28.72M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-0.28
  • YTD % Change-10.06

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.41
  • 52 Week High2.57
  • 52 Week High Date06/13/23
  • 52 Week Low0.89
  • 52 Week Low Date10/30/23
  • Market Cap41.064M
  • Shares Out28.72M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-0.28
  • YTD % Change-10.06

RATIOS/PROFITABILITY

  • EPS (TTM)-1.33
  • P/E (TTM)-1.07
  • Fwd P/E (NTM)-1.97
  • EBITDA (TTM)-20.031M
  • ROE (TTM)-730.48%
  • Revenue (TTM)1.076M
  • Gross Margin (TTM)90.85%
  • Net Margin (TTM)-1,863.35%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cyclo Therapeutics Inc

 

Profile

MORE
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Company’s Trappsol Cyclo is a proprietary formulation of hydroxypropyl beta cyclodextrin. It is an orphan drug designated product in the United States and Europe, and is the subject of four formal clinical trials for Niemann-Pick Disease Type C (NPC) disease. NPC is a rare and...
Markus Sieger
Independent Chairman of the Board
N. Scott Fine
Chief Executive Officer, Director
Jeffrey Tate Ph.D.
Chief Operating Officer, Director
Joshua Fine
Chief Financial Officer, Secretary
Address
6714 Nw 16Th Street,, Suite B
Gainesville, FL
32653
United States

Top Peers

SYMBOLLASTCHG%CHG
VYNE
Vyne Therapeutics Inc
2.76-0.13-4.50%
TXMD
TherapeuticsMD Inc
2.09+0.05+2.45%
SEEL
Seelos Therapeutics Inc
2.32+0.05+19.72%
KALA
KALA BIO Inc
6.76-0.11-1.58%
TLPH
Talphera Inc
1.22+0.20+19.12%